We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
963
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.32%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEACW
1426
CALL
DELISTED
Authentic Equity Acquisition Corp. Warrant
AEACW
$4.37M 0.01%
444,211
MET icon
1427
MetLife
MET
$61.7B
$4.37M 0.01%
+69,643
New +$4.61M
PEGA icon
1428
Pegasystems
PEGA
$5.43B
$4.37M 0.01%
+182,784
New +$5.47M
SHACW
1429
CALL
DELISTED
SCP & CO Healthcare Acquisition Company Warrant
SHACW
$4.35M 0.01%
443,917
MNDY icon
1430
monday.com
MNDY
$3.75B
$4.34M 0.01%
42,061
-149,645
-78% -$18.2M
ST icon
1431
Sensata Technologies
ST
$6.66B
$4.33M 0.01%
104,874
-34,061
-25% -$1.57M
EQHA.WS
1432
CALL
DELISTED
EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
$4.31M 0.01%
438,502
MTD icon
1433
Mettler-Toledo International
MTD
$28.6B
$4.29M 0.01%
+3,734
New +$4.69M
GTACW
1434
CALL
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
$4.29M 0.01%
429,791
RCFA
1435
DELISTED
Perception Capital Corp. IV
RCFA
$4.28M 0.01%
429,955
NPTN
1436
DELISTED
NEOPHOTONICS CORP
NPTN
$4.28M 0.01%
272,134
+203,039
+294% +$3.1M
HZON.WS
1437
CALL
DELISTED
Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HZON.WS
$4.28M 0.01%
431,655
+17,303
+4% +$6.08K
EBAC
1438
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
$4.27M 0.01%
437,091
ABGI
1439
DELISTED
ABG Acquisition Corp. I
ABGI
$4.26M 0.01%
435,509
+104,473
+32% +$1.02M
AFRIW icon
1440
CALL
Forafric Global PLC Warrants
AFRIW
$10.8M
$4.25M 0.01%
+516,879
New +$180K
PHYT.WS
1441
CALL
DELISTED
Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
PHYT.WS
$4.25M 0.01%
425,200
CLBTW
1442
CALL
DELISTED
Cellebrite DI Ltd. Warrants
CLBTW
$4.24M 0.01%
832,130
-37,942
-4% -$34.6K
VMGA
1443
DELISTED
VMG Consumer Acquisition Corp. Class A Common Stock
VMGA
$4.24M 0.01%
424,998
AVXL icon
1444
Anavex Life Sciences
AVXL
$314M
$4.24M 0.01%
423,636
+378,278
+834% +$3.58M
JUN.WS
1445
CALL
DELISTED
Juniper II Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
JUN.WS
$4.23M 0.01%
426,300
NHICW
1446
CALL
DELISTED
NewHold Investment Corp. II Warrant
NHICW
$4.23M 0.01%
428,748
CLRMW
1447
CALL
DELISTED
Clarim Acquisition Corp. Warrant
CLRMW
$4.23M 0.01%
431,013
SVNAW
1448
CALL
DELISTED
7 Acquisition Corp Warrant
SVNAW
$4.23M 0.01%
424,999
ACII.WS
1449
CALL
DELISTED
Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
ACII.WS
$4.23M 0.01%
431,000
XOP icon
1450
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.62B
$4.22M 0.01%
35,300
+15,400
+77% +$2.16M

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 963 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.